These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 2493695)
41. Frequency and significance of antibodies against hepatitis B core (anti-HBc) antigen as the only serological marker for hepatitis B infection in Lebanese blood donors. Ramia S; Ramlawi F; Kanaan M; Klayme S; Naman R Epidemiol Infect; 2005 Aug; 133(4):695-9. PubMed ID: 16050516 [TBL] [Abstract][Full Text] [Related]
42. [Massive and multi-transfusions in polytraumatized patients: long-term serologic markers of hepatitis B, hepatitis C and AIDS]. Schneck HJ; Dobler G; Hundelshausen B; Nathrath M; Drescher M Infusionstherapie; 1991 Oct; 18(5):248-55. PubMed ID: 1663086 [TBL] [Abstract][Full Text] [Related]
43. Value and cost-effectiveness of screening blood donors for antibody to hepatitis B core antigen as a way of detecting window-phase human immunodeficiency virus type 1 infections. The HIV Blood Donor Study Group. Busch MP; Dodd RY; Lackritz EM; AuBuchon JP; Birkmeyer JD; Petersen LR Transfusion; 1997 Oct; 37(10):1003-11. PubMed ID: 9354817 [TBL] [Abstract][Full Text] [Related]
44. Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses. Perrillo RP; Chau KH; Overby LR; Decker RH Gastroenterology; 1983 Jul; 85(1):163-7. PubMed ID: 6406288 [TBL] [Abstract][Full Text] [Related]
45. Significant increase in HBV, HCV, HIV and syphilis infections among blood donors in West Bengal, Eastern India 2004-2005: exploratory screening reveals high frequency of occult HBV infection. Bhattacharya P; Chandra PK; Datta S; Banerjee A; Chakraborty S; Rajendran K; Basu SK; Bhattacharya SK; Chakravarty R World J Gastroenterol; 2007 Jul; 13(27):3730-3. PubMed ID: 17659734 [TBL] [Abstract][Full Text] [Related]
46. Should antibody to hepatitis B core antigen be tested in routine screening of donor corneas for transplant? Mattern RM; Cavanagh HD Cornea; 1997 Mar; 16(2):138-45. PubMed ID: 9071525 [TBL] [Abstract][Full Text] [Related]
47. [Anti-core antibody in HBsAg negative subjects]. Ferroni P; Quartodipalo ME; Zanetti AR Boll Ist Sieroter Milan; 1978 Nov; 57(5):676-9. PubMed ID: 556542 [TBL] [Abstract][Full Text] [Related]
48. Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test. Kleinman SH; Strong DM; Tegtmeier GG; Holland PV; Gorlin JB; Cousins C; Chiacchierini RP; Pietrelli LA Transfusion; 2005 Aug; 45(8):1247-57. PubMed ID: 16078909 [TBL] [Abstract][Full Text] [Related]
49. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population. Prieto M; Gómez MD; Berenguer M; Córdoba J; Rayón JM; Pastor M; García-Herola A; Nicolás D; Carrasco D; Orbis JF; Mir J; Berenguer J Liver Transpl; 2001 Jan; 7(1):51-8. PubMed ID: 11150423 [TBL] [Abstract][Full Text] [Related]
50. Evidence that anti-HBc but not HBV DNA testing may prevent some HBV transmission by transfusion. Allain JP; Hewitt PE; Tedder RS; Williamson LM Br J Haematol; 1999 Oct; 107(1):186-95. PubMed ID: 10520040 [TBL] [Abstract][Full Text] [Related]
51. NAT for HBV and anti-HBc testing increase blood safety. Roth WK; Weber M; Petersen D; Drosten C; Buhr S; Sireis W; Weichert W; Hedges D; Seifried E Transfusion; 2002 Jul; 42(7):869-75. PubMed ID: 12375659 [TBL] [Abstract][Full Text] [Related]
52. [Studies on hepatitis B virus infection in blood donors with positive anti-HBc and negative HBsAg]. Ren F; Li H; Zhao H Zhonghua Yu Fang Yi Xue Za Zhi; 1998 Jan; 32(1):7-9. PubMed ID: 10322742 [TBL] [Abstract][Full Text] [Related]
53. [The use of a test for anti-HBc for prevention of post-transfusion hepatitis B]. Somova AV; Margolina AN; Golosova TV; Fisenko EP; Tsibinogin VV; Loseva VIa Vopr Virusol; 1989; 34(6):749-52. PubMed ID: 2633470 [No Abstract] [Full Text] [Related]
54. Anti-HBc testing in an effort to reduce the incidence of posttransfusion non-A, non-B hepatitis. Kline WE Beitr Infusionther Klin Ernahr; 1987; 18():6-12. PubMed ID: 3125834 [No Abstract] [Full Text] [Related]
55. Prevalence of "anti-HBc alone" among Syrian blood donors. Muselmani W; Habbal W; Monem F J Infect Dev Ctries; 2014 Aug; 8(8):1013-5. PubMed ID: 25116667 [TBL] [Abstract][Full Text] [Related]
56. Anti-HBc screening of blood donors: a comparison of nine anti-HBc tests. Schmidt M; Nübling CM; Scheiblauer H; Chudy M; Walch LA; Seifried E; Roth WK; Hourfar MK Vox Sang; 2006 Oct; 91(3):237-43. PubMed ID: 16958836 [TBL] [Abstract][Full Text] [Related]
57. Anti-HBc testing is reliable for blood donor screening. Smilovici W; Ducos J; Mariniere A Lancet; 1984 May; 1(8384):1024. PubMed ID: 6143954 [No Abstract] [Full Text] [Related]
58. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection. Behzad-Behbahani A; Mafi-Nejad A; Tabei SZ; Lankarani KB; Torab A; Moaddeb A Indian J Med Res; 2006 Jan; 123(1):37-42. PubMed ID: 16567866 [TBL] [Abstract][Full Text] [Related]
59. The value of screening blood donors for antibody to hepatitis B core antigen. Archer AC; Cohen BJ; Mortimer PP J Clin Pathol; 1983 Aug; 36(8):924-8. PubMed ID: 6875019 [TBL] [Abstract][Full Text] [Related]
60. Residual risk of transfusion-transmitted hepatitis B virus (HBV) infection caused by blood components derived from donors with occult HBV infection in Japan. Taira R; Satake M; Momose S; Hino S; Suzuki Y; Murokawa H; Uchida S; Tadokoro K Transfusion; 2013 Jul; 53(7):1393-404. PubMed ID: 23033944 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]